Aglaia Oncology Fund II
Investor profile
Aglaia Oncology Fund II has backed 1 European tech company across 1 funding round in 2018, joining rounds totalling €16M. Most active in Healthtech. Data as of 4 Nov 2026.
Deals
1
distinct rounds
Companies
1
backed
Active span
2018
1 yr
Total round €
€16M
sum of rounds joined
Deals by year
distinct rounds / yearAglaia Oncology Fund II — deals by year — interactive chart.
Data table
| Aglaia Oncology Fund II — deals by year | |
|---|---|
| 2018 | 1 |
Top sectors
by dealsAglaia Oncology Fund II — top sectors — interactive chart.
Data table
| Aglaia Oncology Fund II — top sectors | |
|---|---|
| Healthtech | 1 |
Stages
by dealsAglaia Oncology Fund II — stages — interactive chart.
Data table
| Aglaia Oncology Fund II — stages | |
|---|---|
| Series B | 1 |
Countries
by dealsAglaia Oncology Fund II — countries — interactive chart.
Data table
| Aglaia Oncology Fund II — countries | |
|---|---|
| Netherlands | 1 |
Co-investment network
shared roundsCo-investment network — interactive chart.
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
Frequent co-investors
shared roundsPortfolio
top 30 by total round €| Company | Country | Rounds | Total € |
|---|---|---|---|
| Mimetas | Netherlands | 1 | €16M |